Listen To The Lancet Gastroenterology & Hepatology

In conversation with... Peter De Cruz

Informações:

Synopsis

Peter De Cruz (University of Melbourne) discusses the PREDICT-UC trial of intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis.